We are changing the trajectory of high burden diseases in lower income countries, with a focus on infectious diseases.
Infectious diseases (IDs) such as malaria, tuberculosis (TB) and enteric diseases are among the leading causes of death globally, killing almost 9 million people each year. These
The GSK Africa Open Lab is inviting applications from African scientists at an early stage of their career with an interest in conducting research in infectious diseases.
Africa Open Lab call is for proposals of relevance to the understanding of infectious disease epidemiology, aetiology, prevent
Infectious diseases (IDs) such as malaria, tuberculosis (TB) and enteric diseases are among the leading causes of death globally, killing almost 9 million people each year. These diseases, which are often preventable and treatable, disproportionately affect sub-Sahara African (SSA) populations, caus
GSK plc, formerly GlaxoSmithKline plc, is a British multinational pharmaceutical and biotechnology company with global headquarters in London, England. Established in 2000 by a merger of Glaxo Wellcome and SmithKline Beecham.